Search Results - "Ruiz, Rossana"

Refine Results
  1. 1

    Entrectinib: a potent new TRK, ROS1, and ALK inhibitor by Rolfo, Christian, Ruiz, Rossana, Giovannetti, Elisa, Gil-Bazo, Ignacio, Russo, Antonio, Passiglia, Francesco, Giallombardo, Marco, Peeters, Marc, Raez, Luis

    Published in Expert opinion on investigational drugs (02-11-2015)
    “…Receptor tyrosine kinases (RTKs) and their signaling pathways, control normal cellular processes; however, their deregulation play important roles in malignant…”
    Get more information
    Journal Article
  2. 2

    ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer by Rosas, Gina, Ruiz, Rossana, Araujo, Jhajaira M., Pinto, Joseph A., Mas, Luis

    Published in Critical reviews in oncology/hematology (01-04-2019)
    “…Legend •IHC: Immunohistochemistry •FISH: In situ hybridization with fluorescence •CISH: Chromogenic in situ hybridization •RT-PCR. Reverse transcription…”
    Get full text
    Journal Article
  3. 3

    Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review by Ruiz, Rossana, Herrero, Carmen, Strasser-Weippl, Kathrin, Touya, Diego, St. Louis, Jessica, Bukowski, Alexandra, Goss, Paul E.

    Published in Breast (Edinburgh) (01-10-2017)
    “…The interactions between pregnancy and breast cancer (BC) are complex. Overall, parity is associated with long-term protective effects against BC, however in a…”
    Get full text
    Journal Article
  4. 4

    Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru by Galvez‐Nino, Marco, Ruiz, Rossana, Roque, Katia, Coanqui, Ofelia, Valdivieso, Natalia, Olivera, Mivael, Ganti, Apar Kishor, Mas, Luis

    Published in Thoracic cancer (01-01-2023)
    “…Background Despite the advances in the management of advanced non–small cell lung cancer (NSCLC), the access to genetic profiling and target therapies remains…”
    Get full text
    Journal Article
  5. 5

    Genomic landscape of lung cancer in the young by Ruiz, Rossana, Galvez-Nino, Marco, Roque, Katia, Montes, Jaime, Nuñez, Maria, Raez, Luis, Sánchez-Gambetta, Sergio, Jaúregui, Sandra, Viale, Sandra, Smith, Edward S., Pinto, Joseph A., Mas, Luis

    Published in Frontiers in oncology (29-09-2022)
    “…Background Lung cancer in the young is a rare entity of great interest due to the high frequency of targetable mutations. In this study, we explored the…”
    Get full text
    Journal Article
  6. 6

    Immunotherapeutic Agents in Non-small-cell Lung Cancer Finally Coming to the Front Lines by Ruiz, Rossana, Hunis, Brian, Raez, Luis E.

    Published in Current oncology reports (01-09-2014)
    “…Non-small-cell lung cancer usually carries a dismal prognosis. Novel treatment approaches are clearly warranted. Immunotherapy has emerged as a promising area…”
    Get full text
    Journal Article
  7. 7

    Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up by Vasquez, Jule, Ruiz, Rossana, Aliaga, Karina, Valencia, Fernando, Villena, Marco, Quintana, Shirley, Vidaurre, Tatiana, Casanova, Luis

    Published in JCO global oncology (01-12-2021)
    “…PURPOSE Major progress has occurred in multiple myeloma (MM) treatment in recent years, but this is not seen in low- and middle-income countries. MATERIALS AND…”
    Get full text
    Journal Article
  8. 8

    Elixhauser comorbidity method in predicting death of Spanish inpatients with asplenia and pneumococcal pneumonia by Gea-Izquierdo, Enrique, Ruiz-Urbaez, Rossana, Hernández-Barrera, Valentín, Stich, Michael, Gil-de-Miguel, Ángel

    Published in BMC infectious diseases (20-06-2024)
    “…Pneumococcal pneumonia (PP) is a serious infection caused by Streptococcus pneumoniae (pneumococcus), with a wide spectrum of clinical manifestations. The aim…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Epidemiology of thymic epithelial tumors: 22‐years experience from a single‐institution by Rioja, Patricia, Ruiz, Rossana, Galvez‐Nino, Marco, Lozano, Sophia, Valdiviezo, Natalia, Olivera, Mivael, Cabero, Octavio, Guillen, Maria Eugenia, De La Guerra, Alberto, Amorin, Edgar, Barrionuevo, Carlos, Mas, Luis

    Published in Thoracic cancer (01-02-2021)
    “…Background To assess the correlation of WHO histological classification and Masaoka–Koga staging system of thymic epithelial tumors (TETs) with prognosis…”
    Get full text
    Journal Article
  11. 11

    Diabetic Nephropathy, Retinopathy, and Functional Hypogonadism in a Patient with MODY10: A Case Report by Ruiz-Urbaez, Rossana, Villagómez-Estrada, Mariela Viviana, Reyes-Silva, Carlos, Quishpe-López, Darlyng, Males-Maldonado, David, Salazar-Vega, Jorge, Gea-Izquierdo, Enrique

    Published in Medicina (Kaunas, Lithuania) (01-05-2024)
    “…(1) : Maturity-onset diabetes of the young (MODY) is a group of diabetes caused by gene defects related to insulin secretion. MODY1, MODY2, and MODY3 are the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Mutation pattern of EGFR gene in Peruvian patients with non-small cell lung cancer by Ruiz, Rossana, Galvez-Nino, Marco, Santos, Marco, Doimi, Franco, Mas, Luis, Belmar-Lopez, Carolina

    Published in Journal of clinical oncology (01-06-2024)
    “…e20615 Background: The correct characterization of EGFR mutations is crucial to the proper management of NSCLC patients due to the possibility to treat these…”
    Get full text
    Journal Article
  14. 14

    Características clínicas y pronóstico de los pacientes con linfoma leucemia de células t del adulto by Valdivieso Lama, Natalia, Barrionuevo Cornejo, Carlos, Vidal Ayllon, Judith, Casanova Marquez, Luis, Flores Flores, Claudio, López Chavez, Lourdes, Alcarraz Molina, Cindy, Ruiz Mendoza, Rossana, Quintana Truyenque, Shirley

    Published in Oncología (07-12-2022)
    “…Introducción: El objetivo del presente estudio fue determinar las características clínicas y pronóstico de los pacientes con Leucemia/Linfoma de Células T del…”
    Get full text
    Journal Article
  15. 15

    Entinostat (SNDX-275) for the treatment of non-small cell lung cancer by Ruiz, Rossana, Raez, Luis E, Rolfo, Christian

    Published in Expert opinion on investigational drugs (03-08-2015)
    “…Epigenetic aberrations play an important role in lung carcinogenesis. Chromatin deacetylation is a fundamental mechanism of gene silencing. Histone deacetylase…”
    Get more information
    Journal Article
  16. 16

    Implementation of a comprehensive companion program for patients undergoing systemic cancer treatment by Rioja, Patricia, Ruiz, Rossana, Macetas, Jackeline, Acevedo, Sandra, Guevara, Tania, Quesquen, Mercedes Rogelia, Betancurt, Alejandra, Young, Frank, Montenegro, Paola Catherine

    Published in Journal of clinical oncology (01-06-2023)
    “…e18631 Background: E-PRO has been shown to detect symptoms earlier, allowing for quicker intervention and prevention of downstream complications. We present…”
    Get full text
    Journal Article
  17. 17

    Oncotype Dx score associated to pathological features to better prognosticate the risk of recurrence for breast cancer patients by Namuche, Fernando, Ruiz, Rossana, Morante, Zaida, Flores, Claudio J., Gomez, Henry Leonidas

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only e12562 Background: Oncotype Dx (ODX) prognosticates the risk of recurrence and predicts the benefit of adjuvant chemotherapy in…”
    Get full text
    Journal Article
  18. 18

    Molecular profiling in a Peruvian population with advanced non-small cell lung cancer assessed by NGS by Galvez-Nino, Marco, Belmar-Lopez, Carolina, Ruiz, Rossana, Carrion, Pamela, Diaz, Diana, Chumpitaz, Manuel, Gutierrez, Jose Maria, Requena, María, Pinto, Joseph, Mas, Luis

    Published in Journal of clinical oncology (01-06-2023)
    “…e20612 Background: The use of next generation sequencing (NGS) both at diagnosis and disease progression has allowed us to detect changes in the genetic…”
    Get full text
    Journal Article
  19. 19

    Impact of hemoglobin on survival of young women with cervical cancer treated with concurrent chemoradiotherapy by Castro-Mollo, Melanie Wendy, Galvez-Nino, Marco, Ruiz, Rossana, Roque, Katia, Coanqui, Ofelia, Valdivieso, Natalia, Olivera Hurtado de Mendoza, Mivael, Mas, Luis

    Published in Journal of clinical oncology (01-06-2023)
    “…e17529 Background: Cervical cancer is a global public health problem, with higher impact in many low-income and middle income countries. In Peru, cervical…”
    Get full text
    Journal Article
  20. 20

    Safety of immunotherapy in Peruvian patients with diverse type of malignancies: Experience at a private center by Aguilar, Alfredo, Mariñas, Michelle, Bravo, Leny, Zavaleta, Jenny, Pinto, Joseph, Ruiz, Rossana, Schwarz, Luis

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e19258 Background: Immunotherapy has changed the landscape of cancer treatment. The aim of this work was to describe the adverse events related…”
    Get full text
    Journal Article